Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMGN Amgen	$289.33 -0.1%	$281.82	$253.30 ▼ $346.85	$155.74B	0.51	2.84 million shs	6.80 million shs
ISRG Intuitive Surgical	$509.36 0.0%	$528.03	$413.82 ▼ $616.00	$182.61B	1.67	1.68 million shs	2.83 million shs
MDT Medtronic	$86.30 +0.7%	$84.49	$75.96 ▼ $96.25	$109.95B	0.79	6.93 million shs	13.08 million shs
SYK Stryker	$375.44 +0.6%	$374.95	$314.93 ▼ $406.19	$142.47B	0.91	1.33 million shs	2.01 million shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMGN Amgen	-0.10%	-2.00%	+6.63%	-8.45%	-5.44%
ISRG Intuitive Surgical	-0.03%	-0.55%	-6.89%	+3.43%	+17.09%
MDT Medtronic	+0.73%	-1.03%	+2.10%	-4.50%	+8.21%
SYK Stryker	+0.60%	-0.42%	-1.21%	+1.09%	+7.68%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AMGN Amgen	4.4636 of 5 stars	2.2	4.0	3.3	3.9	3.6	2.5	0.6
ISRG Intuitive Surgical	4.7781 of 5 stars	3.4	5.0	0.0	4.0	3.0	2.5	1.9
MDT Medtronic	4.8767 of 5 stars	3.3	5.0	3.3	4.0	3.5	1.7	1.3
SYK Stryker	4.9062 of 5 stars	3.4	5.0	3.3	4.2	3.0	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMGN Amgen	2.38	Hold	$309.22	6.87% Upside
ISRG Intuitive Surgical	2.70	Moderate Buy	$588.95	15.63% Upside
MDT Medtronic	2.67	Moderate Buy	$97.87	13.40% Upside
SYK Stryker	2.79	Moderate Buy	$427.30	13.81% Upside

Current Analyst Ratings Breakdown

Latest MDT, ISRG, SYK, and AMGN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/16/2025	MDT Medtronic	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/16/2025	MDT Medtronic	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$110.00
6/9/2025	ISRG Intuitive Surgical	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Hold ➝ Sell	$515.00 ➝ $440.00
6/6/2025	MDT Medtronic	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
6/5/2025	ISRG Intuitive Surgical	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy
5/22/2025	ISRG Intuitive Surgical	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$590.00 ➝ $650.00
5/22/2025	MDT Medtronic	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$100.00 ➝ $98.00
5/22/2025	MDT Medtronic	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$105.00 ➝ $101.00
5/22/2025	MDT Medtronic	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$94.00 ➝ $92.00
5/22/2025	SYK Stryker	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$443.00 ➝ $455.00
5/20/2025	AMGN Amgen	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$288.00

(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMGN Amgen	$33.42B	4.65	$30.33 per share	9.54	$10.93 per share	26.47
ISRG Intuitive Surgical	$8.35B	21.86	$7.99 per share	63.78	$46.41 per share	10.98
MDT Medtronic	$33.54B	3.30	$7.80 per share	11.06	$37.62 per share	2.29
SYK Stryker	$22.60B	6.34	$15.17 per share	24.75	$54.13 per share	6.94

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMGN Amgen	$4.09B	$10.96	26.40	13.53	2.62	17.39%	176.11%	12.39%	8/5/2025 (Estimated)
ISRG Intuitive Surgical	$2.32B	$6.82	74.69	66.76	5.40	28.41%	14.43%	12.81%	7/17/2025 (Estimated)
MDT Medtronic	$4.66B	$3.62	23.84	14.80	2.31	13.90%	14.54%	7.83%	8/19/2025 (Estimated)
SYK Stryker	$2.99B	$7.40	50.73	25.32	2.81	12.31%	23.74%	11.25%	7/29/2025 (Estimated)

Latest MDT, ISRG, SYK, and AMGN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/17/2025	Q2 2025	ISRG Intuitive Surgical	$1.92	N/A	N/A	N/A	$2.35 billion	N/A
5/21/2025	Q4 2025	MDT Medtronic	$1.58	$1.62	+$0.04	$0.82	$8.81 billion	$8.93 billion
5/1/2025	Q1 2025	AMGN Amgen	$4.18	$4.90	+$0.72	$3.20	$8.05 billion	$8.15 billion
5/1/2025	Q1 2025	SYK Stryker	$2.73	$2.84	+$0.11	$1.69	$5.68 billion	$5.87 billion
4/22/2025	Q1 2025	ISRG Intuitive Surgical	$1.71	$1.81	+$0.10	$1.92	$2.19 billion	$2.25 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMGN Amgen	$9.52	3.29%	N/A	86.86%	14 Years
ISRG Intuitive Surgical	N/A	N/A	N/A	N/A	N/A
MDT Medtronic	$2.80	3.24%	N/A	77.35%	49 Years
SYK Stryker	$3.36	0.89%	N/A	45.41%	32 Years

Latest MDT, ISRG, SYK, and AMGN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/8/2025	SYK Stryker	quarterly	$0.84	0.88%	6/30/2025	6/30/2025	7/31/2025
5/21/2025	MDT Medtronic	quarterly	$0.71	3.3%	6/27/2025	6/27/2025	7/11/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMGN Amgen	8.70	1.17	0.88
ISRG Intuitive Surgical	N/A	4.98	3.97
MDT Medtronic	0.53	1.85	1.42
SYK Stryker	0.69	1.64	1.00

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMGN Amgen	76.50%
ISRG Intuitive Surgical	83.64%
MDT Medtronic	82.06%
SYK Stryker	77.09%

Insider Ownership

Company	Insider Ownership
AMGN Amgen	0.76%
ISRG Intuitive Surgical	0.70%
MDT Medtronic	0.20%
SYK Stryker	5.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMGN Amgen	28,000	537.71 million	533.62 million	Optionable
ISRG Intuitive Surgical	15,638	358.42 million	355.91 million	Optionable
MDT Medtronic	95,000	1.28 billion	1.28 billion	Optionable
SYK Stryker	53,000	381.69 million	359.17 million	Optionable

MDT, ISRG, SYK, and AMGN Headlines

Recent News About These Companies

Segment Wealth Management LLC Buys 682 Shares of Stryker Corporation (NYSE:SYK)

June 20 at 7:27 AM | marketbeat.com

Stryker Corporation (NYSE:SYK) Shares Sold by ERn Financial LLC

June 19 at 7:41 AM | marketbeat.com

Stryker Corporation (NYSE:SYK) Shares Acquired by Norris Perne & French LLP MI

June 19 at 7:33 AM | marketbeat.com

Plimoth Trust Co. LLC Sells 2,143 Shares of Stryker Corporation (NYSE:SYK)

June 19 at 7:05 AM | marketbeat.com

Catalina Capital Group LLC Lowers Stake in Stryker Corporation (NYSE:SYK)

June 19 at 6:53 AM | marketbeat.com

Sterling Investment Counsel LLC Invests $801,000 in Stryker Corporation (NYSE:SYK)

June 19 at 6:44 AM | marketbeat.com

Boston Trust Walden Corp Sells 7,252 Shares of Stryker Corporation (NYSE:SYK)

June 19 at 6:15 AM | marketbeat.com

Johnson Investment Counsel Inc. Raises Stock Holdings in Stryker Corporation (NYSE:SYK)

June 19 at 5:33 AM | marketbeat.com

Davidson Capital Management Inc. Invests $3.19 Million in Stryker Corporation (NYSE:SYK)

June 19 at 5:33 AM | marketbeat.com

902 Shares in Stryker Corporation (NYSE:SYK) Purchased by Insigneo Advisory Services LLC

June 19 at 4:41 AM | marketbeat.com

Sowell Financial Services LLC Acquires Shares of 2,881 Stryker Corporation (NYSE:SYK)

June 19 at 4:12 AM | marketbeat.com

Stryker council opposes state bill on property tax

June 18 at 4:18 PM | bryantimes.com

Stryker Beats Sales Worker’s Military, Medical Leave Bias Claims

June 18 at 4:18 PM | news.bloomberglaw.com

Soldiers, Strykers and 100-degree temps: Inside Trump’s border military zone

June 18 at 4:18 PM | investing.com

Moody’s upgrades Stryker Corporation to A3, outlook stable

June 18 at 4:18 PM | uk.investing.com

State of Alaska Department of Revenue Grows Stock Position in Stryker Corporation (NYSE:SYK)

June 18 at 7:09 AM | marketbeat.com

NBT Bank N A NY Buys 744 Shares of Stryker Corporation (NYSE:SYK)

June 18 at 4:49 AM | marketbeat.com

Janney Montgomery Scott LLC Buys 732 Shares of Stryker Corporation (NYSE:SYK)

June 18 at 4:14 AM | marketbeat.com

Trust Point Inc. Sells 894 Shares of Stryker Corporation (NYSE:SYK)

June 18 at 4:07 AM | marketbeat.com

Stryker Co. (NYSE:SYK) Position Increased by CENTRAL TRUST Co

June 17, 2025 | marketbeat.com

Wendell David Associates Inc. Has $43.34 Million Position in Stryker Co. (NYSE:SYK)

June 17, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

3 Defense Stocks That Will Profit From a Golden Dome
By Chris Markoch | May 30, 2025
View 3 Defense Stocks That Will Profit From a Golden Dome
Analysts Think These Stocks Could More Than Double in Value
By Nathan Reiff | May 23, 2025
View Analysts Think These Stocks Could More Than Double in Value
Intel’s Turnaround May Be the Best Bet No One’s Watching
By Jeffrey Neal Johnson | May 30, 2025
View Intel’s Turnaround May Be the Best Bet No One’s Watching
Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 Earnings
By Thomas Hughes | May 27, 2025
View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 Earnings
Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?
By Leo Miller | June 19, 2025
View Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?

MDT, ISRG, SYK, and AMGN Company Descriptions

Amgen NASDAQ:AMGN

$289.33 -0.30 (-0.10%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$289.95 +0.62 (+0.21%)

As of 06/20/2025 07:58 PM Eastern

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Intuitive Surgical NASDAQ:ISRG

$509.36 -0.13 (-0.03%)

Closing price 06/20/2025 04:00 PM Eastern

Extended Trading

$511.78 +2.43 (+0.48%)

As of 06/20/2025 07:59 PM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Medtronic NYSE:MDT

$86.30 +0.57 (+0.66%)

Closing price 06/20/2025 03:59 PM Eastern

Extended Trading

$86.96 +0.66 (+0.76%)

As of 06/20/2025 07:51 PM Eastern

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Stryker NYSE:SYK

$375.44 +2.18 (+0.58%)

Closing price 06/20/2025 03:59 PM Eastern

Extended Trading

$375.84 +0.41 (+0.11%)

As of 06/20/2025 06:43 PM Eastern

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time